EVD (also called ventriculostomy catheter), or a bolt-secured intraventricular catheter. Physicians and nurses act collaboratively to deliver appropriate interventions aimed at keeping ICP within normal limits, 15 using a wide variety of methods for monitoring, treating, and documenting ICP values.
The most common method of facilitating CSF drainage in SAH is the use of an EVD catheter and either continuous or intermittent CSF drainage. Results from a nonrandomized observational trial of continuous versus in termittent CSF drainage have been reported in 2 separate articles describing medical and nursing-related outcomes. 2, 9 In the first article, Kim et al. 9 reported no difference in the incidence of vasospasm between groups, but found that patients undergoing continuous drainage may have a higher rate of required shunt placement and ventricular catheter-related complications. A second study de signed to compare nursing outcomes for continuous and intermittent CSF drainage found no significant differences in peak ICP, total volume or duration of CSF drainage, or the total number of EVDs used during the care of the patient. The study was unable to detect a significant difference in the rates of vasospasm between groups.
2 Furthermore, Olson et al. 16 reported high practice variation among 14 hospitals participating in an observational study of ICP monitoring.
These studies raised questions regarding EVD management in the clinical setting, yet their sample sizes were small and they lacked a randomized design. However, the results of the studies indicated the need for further investigation into the outcomes of continuous versus intermittent drainage. Despite the need for research in this area, there has yet to be a randomized clinical trial conducted that examines the outcomes of these 2 approaches for ICP management. Therefore, the purpose of this study was, in a randomized clinical trial, to explore how 2 different strategies for managing ICP in SAH patients impact the incidence of cerebral artery vasospasm.
Methods
The study received full approval by the Duke University Institutional Review Board as an unblinded randomized clinical trial. This study was registered with the ClinicalTrials.gov database, and its registration number is NCT01169454. Sample size estimates were based on the primary outcome of cerebral artery vasospasm using data from a published observational trial. 11 A sample of 86 patients (43 per group) was determined to be sufficient to detect a significant difference. The desired number of patients was rounded upward to 100 as a more conservative estimate. An interim analysis of complications was performed after 60 patients had completed the trial. The results of the interim analysis were discussed by the DSMB, and the trial was closed to enrollment based on recommendations from the DSMB.
Patients
Adult patients were considered eligible if they were admitted to the neurocritical care unit with a diagnosis of aneurysmal SAH and if an EVD was placed by a member of the neurosurgical team within 72 hours of admission.
Patients were recruited from the neurocritical care unit after being identified by the medical team as meeting the initial eligibility requirements (that is, adults with SAH and an EVD in situ). Due to the critical illness and nature of SAH, consent was obtained from each patient's legally authorized representative.
Clinical Management
Individuals in both study groups were treated according to the institutional standard of care. Decisions regarding management of a ruptured aneurysm and treatment thresholds for CSF diversion were made by the attending neurosurgeon. Serial neurological assessments were performed every 2 hours by the nursing staff and at least daily by the physician in the neurocritical care unit. Transcranial Doppler ultrasonography was performed daily in the morning beginning on the first morning after admission. All TCD studies were reviewed and interpreted by a certified physician. The decision to undertake additional imaging (CTA or direct cerebral angiography) to assess for cerebral artery vasospasm was based on available clinical data (physical examination and TCD results). All patients received the standard of care for vasospasm prevention and treatment (for example, nimodipine, intravenous fluids, and ICU monitoring).
Study Protocol
Patients for whom consent was provided were randomized to 1 of 2 groups using a random number generator. The primary attending physician prescribed a treatment threshold (for example, treat for ICP > 15 mm Hg), and the nursing and medical staff were provided with a printed protocol that described how and when CSF drainage should occur based on the prescribed treatment threshold ( Table 1 ). The first group was designated as the "open-EVD" group, and staff were instructed to primarily keep the EVD open to drain CSF, but to close the EVD and monitor and record ICP at least once per hour. The second group was designated as the "monitor-ICP" group, and staff were instructed to primarily monitor ICP and only open the EVD to drain CSF if the ICP exceeded the prescribed threshold for at least 5 minutes.
Measures
Patient demographics, Hunt and Hess scores, Fisher scores, and additional baseline data were collected from all study participants. The following measures were collected as outcome measures.
Vasospasm. Vasospasm was defined as the composite of both clinically symptomatic spasm and imaging-positive spasm. Clinical vasospasm was defined as neurological deficits resulting from cerebral ischemia in the setting of imaging evidence of vasoconstriction (based on TCD, CTA, or catheter angiography). In this study, imaging positive for vasospasm was determined primarily through TCD studies. Spasm at our institution is defined as any middle cerebral artery or anterior cerebral artery velocity exceeding 130 cm/second with a Lindegaard ratio greater than 3.0. Computed tomography angiograms and catheter angiograms were compared with those obtained at baseline, and any patient whose artery had greater than 25% narrowing compared with baseline was considered to have vasospasm. Severe spasm was defined as greater than 75% narrowing or TCD velocities greater than 200 cm/second with a Lindegaard ratio greater than 6.
Complications. Complications were defined as a CSF leak (any notation of CSF drainage at the insertion site), hemorrhage (intracranial hemorrhage), self device removal (any incidence of unplanned removal of the EVD other than by a physician), ventriculitis (defined as a positive CSF culture), and a nonpatent or clogged EVD (defined as any incident wherein there was no CSF drainage possible and a flat ICP waveform such that a physician was required to manipulate the EVD catheter to resume patency).
Length of Stay.
Length of stay was measured by the number of days the individual was in the neurocritical care unit.
Morbidity and Mortality.
Mortality was defined as a patient death occurring before hospital discharge. Morbidity was measured using mRS scores at hospital discharge. The mRS is a widely used clinical outcome measure for patients suffering from stroke. 3, 24 It measures the degree of disability after a stroke and has strong clinical reliability.
Data Analysis
All data were collected via chart abstraction and entered into an electronic case report form for each patient. All personal subject information was removed to protect each individual's confidentiality. All data collected were entered directly into an electronic spreadsheet and converted to SAS 9.4 for analysis. Descriptive statistics were performed to describe measures of central tendency. Nonparametric data were explored using the WilcoxonMann-Whitney test. Hypothesis testing was conducted with a level of significance set at alpha = 0.05.
Results
The study enrolled 60 patients with SAH; 34 were randomized to the open-EVD group and 26 to the monitor-ICP group. There were 15 individuals who met inclusion criteria but declined participation (consent failure). There were no significant intergroup differences in baseline characteristics, severity of illness, or aneurysm treatment (Table 2) . In the open-EVD group, patients' mean age was 57.2 years and 73.5% were female; these characteristics were similar to those in the monitor-ICP group in which mean age was 59.4 years and 69.3% were female (p = 0.501 and 0.720, respectively). Subjects in both groups were predominantly non-Hispanic (over 95%) and Caucasian (over 60%). Injury severity was measured upon admission; the median Hunt and Hess scores were 3 and The primary outcome of the study was composite vasospasm, namely, the presence of both clinically symptomatic spasm and imaging-positive spasm (Table 3) . Vasospasm monitoring by TCD ultrasonography was performed daily in all patients, and vasospasm was defined as a Lindegaard ratio greater than 3.0, with a mean TCD velocity greater than 130 cm/second (mild), greater than 150 cm/second (moderate), and greater than 200 cm/second (severe). Using TCD criteria, there was no significant There were no intergroup differences for secondary outcomes associated with CSF drainage ( 
Discussion
The results of this randomized clinical trial extend the findings from the observational trial of continuous and intermittent CSF drainage for patients with SAH.
2,9
The significantly higher complication rate associated with continuous CSF drainage in the open-EVD group resulted in a decision by the DSMB to close the study to further enrollment. The most serious complication was a positive CSF culture. The percentage of patients with ventriculitis was clinically relevant but not statistically significantly different (17.6% in the open-EVD group The infection rate in the open-EVD group is nearly twice the reported average. Kim et al. summarized the results from 17 studies and reported an average infection rate of 9.5% (range 0%-22%). 10 In the observational study of continuous and intermittent CSF drainage, 12.5% of patients who underwent continuous CSF drainage versus 0% of those who underwent intermittent drainage were diagnosed with ventriculitis. 9 To fully explore the relative risk of infection for patients undergoing continuous CSF drainage, we combined the sample populations from the randomized and observational studies conducted at our institution. The odds of ventriculitis developing in the open-EVD group (15.5%, or 9 of 58 patients) compared with the monitor-ICP group rate (2.6%, or 1 of 39 patients) remained clinically relevant but not statistically significant with a wide confidence interval (OR 6.98, 95% CI 0.947-57.513). The overall rates of ventriculitis of 11.7% (7 of 60 patients) in the randomized study and 8.1% (3 of 37 patients) in the observational study at our institution are similar to reported averages. 10 This finding further supports the belief that the difference in infection rates is related to group differences and not institutional differences.
The association between the higher number of nonpatent EVDs and ventriculitis in the open-EVD group may be explained by a higher likelihood of contamination each time the neurosurgeon accesses the closed sterile system during flushing to restore flow. Maintaining a patent lumen is vital to proper functioning of EVDs. In both the current randomized study and the previous observational study, the rate of nonpatent EVDs (those that required flushing to resume patency) was higher in the open-EVD group. 9 Excluding complications that are potentially patient dependent (self device removal and CSF leakage or hemorrhage) did not reduce the higher odds of complication (OR 5.50, as reported above) in the open-EVD group.
A power analysis performed prior to the present study determined that a sample size of 86 subjects would be sufficient to explore the impact of the 2 different drainage mechanisms on vasospasm rates. The diagnosis of vasospasm was made by the neurointensivist based on the combination of clinical examination and TCD results. Serial neurological examinations and TCD studies were completed at least daily for all patients. Not all patients in the study underwent CTA and/or direct cerebral angiography to diagnose vasospasm, but, consistent with the literature, there were no cases where vasospasm was identified by CTA or angiography, and was also not identified by the combination of neurological examination and TCD ultrasonography. 8 Although the trial was stopped early and there was no statistically significant difference in the primary outcome of vasospasm, there was a trend toward significance in favor of the open-EVD group. It is not possible to know what the final rates of vasospasm would have been if the trial had been allowed to continue to full enrollment. However, one could speculate that the trend toward significance suggests that, if a mechanism could be determined to reduce the risk of complications from open-EVD, there is a potential for reducing the risk of vasospasm and thereby benefiting the patient. The finding of clinically significant higher rates of vasospasm is, however, dependent on the assumption that vasospasm can be equally well identified by angiography or TCD ultrasonography (Table 3 ). This assumption is generally considered not valid; TCD ultrasonography is a poor surrogate for diagnosing vasospasm. 5 The lack of observed difference in secondary outcomes such as LOS in the ICU and functional status at discharge may be the result of stopping the trial early. However, the lack of intergroup differences is consistent with results from the observational study.
9 Furthermore, the standard of care at our institution is a minimum LOS of 14 days for all SAH patients (survivors), thus creating a potential bias toward longer LOS. To fully explore functional outcomes, mRS scores were dichotomized first based on dependence 3 (mRS score of 1 vs 2-6) and then based on extremely poor outcome (mRS score of [5] [6] under the assumption that patients view a major stroke as an outcome as bad as or worse than death.
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Limitations
There are several important limitations that should be recognized. First, the sample size of 60 patients is not sufficient to reject the null hypothesis of no difference in The inclusion criteria for this study were defined only as aneurysmal SAH requiring EVD placement based on the discretion of the attending neurosurgeon. This broad inclusion criterion increases the external validity of the study, but the limited internal validity is a potential bias. Future research may find increased benefit or harm associated with different inclusion criteria (for example, only including patients with high Fisher scores). The use of mRS scores at discharge may not accurately reflect functional outcomes in this population given that recovery from CNS injury may be delayed. It is generally accepted that early assessment of poststroke disability is less informative than are 3-or 6-month outcome data. 21 Having 90-day outcome data would be beneficial to understanding the full impact of the intervention.
It is a recognized limitation that groups were unequal in size. Only 26 patients were randomized to the monitor-ICP group compared with 34 in the open-EVD group. To remain conservative and control for lost-to-follow-up rates, randomization was performed using a random number table and randomization without replacement with an estimated sample size of 100 subjects. The study was terminated early after the DSMB recommended that the study should stop enrollment because the results of the interim data analysis were clinically significant in finding a higher risk of complication among patients randomized to the open-EVD group.
Conclusions
Continuous CSF drainage with only intermittent ICP monitoring is associated with a significantly greater risk of complications than CSF drainage triggered by ICP treatment threshold. The clinically relevant, but not statistically significant, difference in vasospasm deserves greater attention. Future research should focus on determining the optimal treatment threshold to maximize CSF drainage for patients with SAH who receive ICP monitoring via EVD. 
